跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PRICELINE IBUPROFEN SODIUM 256mg (as sodium dihydrate) film coated tablet blister pack (new formulation) - TGA Drug Approval Details
Approvals
/
TGA
/
PRICELINE IBUPROFEN SODIUM 256mg (as sodium dihydrate) film coated tablet blister pack (new formulation)
Approved
STANDARD
PRICELINE IBUPROFEN SODIUM 256mg (as sodium dihydrate) film coated tablet blister pack (new formulation)
Neo Health (OTC) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
97ed19a73d69bed2
Company
Neo Health (OTC) Pty Ltd
Type
Standard
Approval Details
Approval Id
97ed19a73d69bed2
Product Name
PRICELINE IBUPROFEN SODIUM 256mg (as sodium dihydrate) film coated tablet blister pack (new formulation)
Artg Id
408196
Artg Name
PRICELINE IBUPROFEN SODIUM 256mg (as sodium dihydrate) film coated tablet blister pack (new formulation)
Sponsor
Neo Health (OTC) Pty Ltd
Company Detail Path
/organization/neo-health-otc-pty-ltd
Artg Date
2023-04-27
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
97ed19a73d69bed2
Type
Standard
Back to TGA Approvals